StocksDeepDive
Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC

RIGL — Rigel Pharmaceuticals, Inc.

EXPENSIVE (MOS -98.9%) · Quality 55/100

Price
46.64
Intrinsic value
23.45
Margin of safety
-98.9%
Implied growth (reverse DCF)
+8.8%
model assumes +0.0%
Value Score
5.5
Quality
55
Psychology
-11.8
Discovery
29.3
price/volume attention only
Moat score
67.5
erosion: none

Value Score: bottom 7% of Russell 3000 · Quality: top 46%

Open the interactive Deep Dive for RIGL →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/RIGL - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is RIGL undervalued?

As of 2026-09-19, RIGL trades at 46.64 against a computed intrinsic value of 23.45 (-98.9% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Rigel Pharmaceuticals, Inc.'s Value Score?

Rigel Pharmaceuticals, Inc.'s Value Score is 5.5 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.